Logo image of TN8.DE

THERMO FISHER SCIENTIFIC INC (TN8.DE) Stock Fundamental Analysis

FRA:TN8 - Deutsche Boerse Ag - US8835561023 - Common Stock - Currency: EUR

390.7  +1.85 (+0.48%)

Fundamental Rating

5

Overall TN8 gets a fundamental rating of 5 out of 10. We evaluated TN8 against 18 industry peers in the Life Sciences Tools & Services industry. TN8 scores excellent on profitability, but there are some minor concerns on its financial health. TN8 has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

TN8 had positive earnings in the past year.
TN8 had a positive operating cash flow in the past year.
Each year in the past 5 years TN8 has been profitable.
TN8 had a positive operating cash flow in each of the past 5 years.
TN8.DE Yearly Net Income VS EBIT VS OCF VS FCFTN8.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

1.2 Ratios

TN8 has a Return On Assets of 6.50%. This is amongst the best in the industry. TN8 outperforms 88.89% of its industry peers.
Looking at the Return On Equity, with a value of 13.04%, TN8 belongs to the top of the industry, outperforming 94.44% of the companies in the same industry.
TN8 has a Return On Invested Capital of 6.25%. This is in the better half of the industry: TN8 outperforms 61.11% of its industry peers.
The Average Return On Invested Capital over the past 3 years for TN8 is in line with the industry average of 6.95%.
Industry RankSector Rank
ROA 6.5%
ROE 13.04%
ROIC 6.25%
ROA(3y)6.58%
ROA(5y)7.42%
ROE(3y)13.81%
ROE(5y)15.77%
ROIC(3y)6.66%
ROIC(5y)7.62%
TN8.DE Yearly ROA, ROE, ROICTN8.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

With an excellent Profit Margin value of 15.24%, TN8 belongs to the best of the industry, outperforming 94.44% of the companies in the same industry.
TN8's Profit Margin has been stable in the last couple of years.
TN8's Operating Margin of 18.18% is fine compared to the rest of the industry. TN8 outperforms 72.22% of its industry peers.
TN8's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 41.34%, TN8 is in line with its industry, outperforming 55.56% of the companies in the same industry.
TN8's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 18.18%
PM (TTM) 15.24%
GM 41.34%
OM growth 3Y-12.04%
OM growth 5Y1.61%
PM growth 3Y-9.15%
PM growth 5Y0.42%
GM growth 3Y-5.61%
GM growth 5Y-1.03%
TN8.DE Yearly Profit, Operating, Gross MarginsTN8.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

4

2. Health

2.1 Basic Checks

TN8 has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
TN8 has less shares outstanding than it did 1 year ago.
The number of shares outstanding for TN8 has been reduced compared to 5 years ago.
TN8 has a better debt/assets ratio than last year.
TN8.DE Yearly Shares OutstandingTN8.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
TN8.DE Yearly Total Debt VS Total AssetsTN8.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

2.2 Solvency

The Debt to FCF ratio of TN8 is 5.71, which is a neutral value as it means it would take TN8, 5.71 years of fcf income to pay off all of its debts.
TN8 has a Debt to FCF ratio (5.71) which is comparable to the rest of the industry.
TN8 has a Debt/Equity ratio of 0.65. This is a neutral value indicating TN8 is somewhat dependend on debt financing.
TN8 has a worse Debt to Equity ratio (0.65) than 61.11% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 5.71
Altman-Z N/A
ROIC/WACC0.63
WACC9.86%
TN8.DE Yearly LT Debt VS Equity VS FCFTN8.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.3 Liquidity

A Current Ratio of 1.93 indicates that TN8 should not have too much problems paying its short term obligations.
The Current ratio of TN8 (1.93) is better than 77.78% of its industry peers.
TN8 has a Quick Ratio of 1.50. This is a normal value and indicates that TN8 is financially healthy and should not expect problems in meeting its short term obligations.
TN8's Quick ratio of 1.50 is amongst the best of the industry. TN8 outperforms 83.33% of its industry peers.
Industry RankSector Rank
Current Ratio 1.93
Quick Ratio 1.5
TN8.DE Yearly Current Assets VS Current LiabilitesTN8.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 0.23% over the past year.
Measured over the past years, TN8 shows a quite strong growth in Earnings Per Share. The EPS has been growing by 12.12% on average per year.
The Revenue has been growing slightly by 2.05% in the past year.
Measured over the past years, TN8 shows a quite strong growth in Revenue. The Revenue has been growing by 10.92% on average per year.
EPS 1Y (TTM)0.23%
EPS 3Y-4.52%
EPS 5Y12.12%
EPS Q2Q%-0.19%
Revenue 1Y (TTM)2.05%
Revenue growth 3Y3.03%
Revenue growth 5Y10.92%
Sales Q2Q%2.98%

3.2 Future

Based on estimates for the next years, TN8 will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.79% on average per year.
Based on estimates for the next years, TN8 will show a small growth in Revenue. The Revenue will grow by 4.89% on average per year.
EPS Next Y3.18%
EPS Next 2Y6.76%
EPS Next 3Y8.41%
EPS Next 5Y8.79%
Revenue Next Year2.49%
Revenue Next 2Y3.65%
Revenue Next 3Y4.39%
Revenue Next 5Y4.89%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
TN8.DE Yearly Revenue VS EstimatesTN8.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10B 20B 30B 40B 50B
TN8.DE Yearly EPS VS EstimatesTN8.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10 20 30

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 20.79 indicates a rather expensive valuation of TN8.
72.22% of the companies in the same industry are more expensive than TN8, based on the Price/Earnings ratio.
TN8's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.48.
The Price/Forward Earnings ratio is 18.27, which indicates a rather expensive current valuation of TN8.
Based on the Price/Forward Earnings ratio, TN8 is valued cheaply inside the industry as 88.89% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of TN8 to the average of the S&P500 Index (34.04), we can say TN8 is valued slightly cheaper.
Industry RankSector Rank
PE 20.79
Fwd PE 18.27
TN8.DE Price Earnings VS Forward Price EarningsTN8.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as TN8.
TN8's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 27.84
EV/EBITDA 18.53
TN8.DE Per share dataTN8.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates TN8 does not grow enough to justify the current Price/Earnings ratio.
TN8 has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)6.53
PEG (5Y)1.72
EPS Next 2Y6.76%
EPS Next 3Y8.41%

3

5. Dividend

5.1 Amount

TN8 has a yearly dividend return of 0.38%, which is pretty low.
Compared to an average industry Dividend Yield of 0.73, TN8 is paying slightly less dividend.
With a Dividend Yield of 0.38, TN8 pays less dividend than the S&P500 average, which is at 2.39.
Industry RankSector Rank
Dividend Yield 0.38%

5.2 History

On average, the dividend of TN8 grows each year by 15.37%, which is quite nice.
Dividend Growth(5Y)15.37%
Div Incr Years4
Div Non Decr Years4
TN8.DE Yearly Dividends per shareTN8.DE Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

TN8 pays out 9.26% of its income as dividend. This is a sustainable payout ratio.
TN8's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP9.26%
EPS Next 2Y6.76%
EPS Next 3Y8.41%
TN8.DE Yearly Income VS Free CF VS DividendTN8.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B
TN8.DE Dividend Payout.TN8.DE Dividend Payout, showing the Payout Ratio.TN8.DE Dividend Payout.PayoutRetained Earnings

THERMO FISHER SCIENTIFIC INC

FRA:TN8 (8/8/2025, 7:00:00 PM)

390.7

+1.85 (+0.48%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)07-23 2025-07-23/bmo
Earnings (Next)10-21 2025-10-21/bmo
Inst Owners92.18%
Inst Owner ChangeN/A
Ins Owners0.09%
Ins Owner ChangeN/A
Market Cap147.49B
Analysts80.57
Price Target483.56 (23.77%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.38%
Yearly Dividend1.3
Dividend Growth(5Y)15.37%
DP9.26%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.77%
Min EPS beat(2)-0.07%
Max EPS beat(2)1.61%
EPS beat(4)2
Avg EPS beat(4)0.72%
Min EPS beat(4)-0.34%
Max EPS beat(4)1.69%
EPS beat(8)5
Avg EPS beat(8)1.74%
EPS beat(12)7
Avg EPS beat(12)1.2%
EPS beat(16)11
Avg EPS beat(16)5.31%
Revenue beat(2)2
Avg Revenue beat(2)0.45%
Min Revenue beat(2)0.28%
Max Revenue beat(2)0.62%
Revenue beat(4)3
Avg Revenue beat(4)-0.1%
Min Revenue beat(4)-1.36%
Max Revenue beat(4)0.62%
Revenue beat(8)5
Avg Revenue beat(8)-0.15%
Revenue beat(12)7
Avg Revenue beat(12)0.84%
Revenue beat(16)11
Avg Revenue beat(16)3.32%
PT rev (1m)-1.83%
PT rev (3m)-13.01%
EPS NQ rev (1m)-0.41%
EPS NQ rev (3m)-4.79%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.95%
Revenue NQ rev (1m)0.42%
Revenue NQ rev (3m)-0.24%
Revenue NY rev (1m)0.31%
Revenue NY rev (3m)0.02%
Valuation
Industry RankSector Rank
PE 20.79
Fwd PE 18.27
P/S 3.98
P/FCF 27.84
P/OCF 22.67
P/B 3.4
P/tB N/A
EV/EBITDA 18.53
EPS(TTM)18.79
EY4.81%
EPS(NY)21.39
Fwd EY5.47%
FCF(TTM)14.03
FCFY3.59%
OCF(TTM)17.23
OCFY4.41%
SpS98.28
BVpS114.8
TBVpS-27.11
PEG (NY)6.53
PEG (5Y)1.72
Profitability
Industry RankSector Rank
ROA 6.5%
ROE 13.04%
ROCE 8.88%
ROIC 6.25%
ROICexc 6.74%
ROICexgc 28.04%
OM 18.18%
PM (TTM) 15.24%
GM 41.34%
FCFM 14.28%
ROA(3y)6.58%
ROA(5y)7.42%
ROE(3y)13.81%
ROE(5y)15.77%
ROIC(3y)6.66%
ROIC(5y)7.62%
ROICexc(3y)7.33%
ROICexc(5y)8.51%
ROICexgc(3y)36.42%
ROICexgc(5y)41.56%
ROCE(3y)9.48%
ROCE(5y)10.9%
ROICexcg growth 3Y-8.22%
ROICexcg growth 5Y1.35%
ROICexc growth 3Y-8.88%
ROICexc growth 5Y2.89%
OM growth 3Y-12.04%
OM growth 5Y1.61%
PM growth 3Y-9.15%
PM growth 5Y0.42%
GM growth 3Y-5.61%
GM growth 5Y-1.03%
F-Score7
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 5.71
Debt/EBITDA 3.08
Cap/Depr 49.03%
Cap/Sales 3.26%
Interest Coverage 250
Cash Conversion 70.63%
Profit Quality 93.71%
Current Ratio 1.93
Quick Ratio 1.5
Altman-Z N/A
F-Score7
WACC9.86%
ROIC/WACC0.63
Cap/Depr(3y)51.6%
Cap/Depr(5y)63.11%
Cap/Sales(3y)3.9%
Cap/Sales(5y)4.54%
Profit Quality(3y)109.9%
Profit Quality(5y)104.9%
High Growth Momentum
Growth
EPS 1Y (TTM)0.23%
EPS 3Y-4.52%
EPS 5Y12.12%
EPS Q2Q%-0.19%
EPS Next Y3.18%
EPS Next 2Y6.76%
EPS Next 3Y8.41%
EPS Next 5Y8.79%
Revenue 1Y (TTM)2.05%
Revenue growth 3Y3.03%
Revenue growth 5Y10.92%
Sales Q2Q%2.98%
Revenue Next Year2.49%
Revenue Next 2Y3.65%
Revenue Next 3Y4.39%
Revenue Next 5Y4.89%
EBIT growth 1Y5.17%
EBIT growth 3Y-9.38%
EBIT growth 5Y12.7%
EBIT Next Year13.42%
EBIT Next 3Y8.96%
EBIT Next 5Y8.38%
FCF growth 1Y5.4%
FCF growth 3Y2.29%
FCF growth 5Y12.42%
OCF growth 1Y-1.49%
OCF growth 3Y-2.36%
OCF growth 5Y11.75%